J Acupunct Res Search

CLOSE


Best Practice

  • HOME
  • FOR THIS JOURNAL
  • Best Practice

Posted September 22, 2020

Table of Contents

1. Website

The URL address of official journal web site is http://e-jar.org
Aims & Scope statement: https://www.e-jar.org/about/index.php
The Journal of Acupuncture Research (JAR), founded in 1983, is the official journal of the Korean Acupuncture & Moxibustion Medicine Society. Manuscripts undergo stringent peer review; those accepted for publication are published open access. JAR is published quarterly in February, May, August, and November.
The journal, by providing a platform for dissemination and discussion, aims to strengthen the scientific understanding of the safety and effectiveness (efficacy) of acupuncture and related therapies in integrative medicine as well as in traditional medicine.
There is a long history of research on acupuncture. Work that takes into account historical empirical evidence, incorporating a broad evidence-based approach to acupuncture, and that is of interest and relevance to those involved in the practice, research, and education of acupuncture-based therapies in health care would be welcome.
  • JAR considers original articles, review articles, case reports, short communications and letters on:
  • • Acupuncture (electroacupuncture, laser acupuncture, acupotomy, embedding therapy, acupuncture needling, the development of new acupuncture techniques, exploration of new acupoints)
  • • moxibustion
  • • cupping
  • • pharmacopuncture (herbal acupuncture, acupoint injection, aqua-acupuncture)
  • • the meridian system and other meridian-related studies (meridian diagnosis, acupressure, chuna/tuina, herbal medicine)
Readership:
The Journal of Acupuncture Research (JAR) is primarily for Korean Medicine doctors and integrative medicine researchers from around the world. Its readership can be expanded to other positions:
  • • Researchers interested in acupuncture and related therapies in integrative medicine as well as in traditional medicine, and Asia-specific chronic musculoskeletal condition(pain) issues
  • • Students can seek to understand the recent trends in acupuncture and related therapies in integrative medicine as well as in traditional medicine.
  • • Professors on acupuncture medicine can access and adopt a variety of data for education;
  • • Policy makers are able to reflect the results of the articles to the national health insurance policies
Korean Medicine doctors or people involved in the practice, research, and education of acupuncture-based therapies in health care throughout the world can submit a manuscript if the scope is appropriate for JAR. Manuscripts should be submitted in English.

2. Name of journal

The official journal name is Journal of Acupuncture Research. Abbreviated title is J Acupunct Res.

3. Peer review process: https://www.e-jar.org/authors/authors.php

Peer review Process

This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. All submitted manuscripts are screened for duplication through Crosscheck (https://app.ithenticate.com) before review.

Method of peer review

The Editorial Office of Journal of Acupuncture Research receives and reviews all submitted manuscripts, and all submitted manuscripts are considered confidential. The submitted manuscripts are initially screened for the format. Once the manuscript is provisionally accepted, it is sent to the three most relevant referees for review. The referees are selected by the editor from the Editorial Board's database or the board members' recommendation. The referees are then requested to evaluate based on originality, validity, presentation, and importance and interest, and, when considered necessary, statistics.
Acceptance of a manuscript depends on the evaluation, critiques, and recommended decision made by the referees. A referee may recommend 'accept', 'minor revision', 'major revision' and 'reject'. Upon opposing recommended decisions between referees, or author and referee(s), the Editor-in-Chief has the full right to decide whether the manuscript will be published in the journal. Three repeated decisions of 'major revisions' are regarded as a 'reject' and rejected papers will not be considered further.
The reviewed manuscripts with comments, recommended directions, and revisions are returned to the corresponding author. The corresponding author is to submit the revised manuscript accompanied by point-to-point replies to the comments given by the editor and how the revisions have been made. There should be a reasonable explanation for any noncompliance with the recommendations. In cases where references, tables, or figures are moved, added or deleted during the revision process, renumbering must be done so that all references, tables, and figures are cited in numeric order. If the revised paper is not received within 2 months of decision, the manuscript is considered to have been withdrawn.When the final decision on the acceptance of the manuscript is made, the Editorial Office notifies the corresponding author. The peer-review process takes approximately 8-12 weeks.

4. Ownership, journal management team, and publishing credentials

The journal is owned by the Korean Acupuncture & Moxibustion Medicine Society(http://www.kamms.org)
The management team is as follows (Jan 2020 – Dec 2021):
Editor-in-Chief Ho-Sueb Song Gil Korean Medical Hospital, Gachon University, Korea
Editors for the review
Gi Young Yang Pusan National University School of Korean Medicine, Korea
Eun jung Kim College of Oriental Medicine, Dongguk University, Korea
Byung-Kwan Seo Kyung Hee University Hospital at Gangdong, Korea
Myeong Soo Lee Korea Institute of Oriental Medicine, Korea
Sang-Hoon Lee Kyung Hee University Korean Medicine Hospital, Korea
Managing Editor
Jihye Hwang Gil Korean Medical Hospital, Gachon University, Korea
Statistical Editor
Seung-Deok Lee Dongguk University Los Angeles, USA
Assistant Editor
Haeni Seo Gil Korean Medical Hospital, Gachon University, Korea
Manuscript Editor
Kathryn Whelan London, UK
Journal Manager and publishing service Hyunjin Jung E-Tree Publishing, Korea
Website and JATS XML Producer Im, Jeonghee, M2Community, Korea

5. Governing body

The governing body is the editorial board of Acupuncture of Research.

6. Editorial team and contact information: https://www.e-jar.org/about/editorial.php

The Editorial team is available from Editorial Board page at the front part of the journal
Editor-in-Chief : Ho-Sueb Song Gil Korean Medical Hospital, Gachon University, Korea
E-mail : docsong70@hanmail.net
Editorial Office
Haeni Seo
Korean Acupuncture & Moxibustion Medicine Society
Gil Korean Medical Hospital, Gachon University, Keunumul-Ro, Chung-Ku, Inchoen 22138, Korea
Tel: +82-70-7606-6353,4
Fax: +82-32-232-3334
E-mail: jared@e-jar.org

7. Copyright and licensing

Copyright

Published manuscripts become the permanent property of Korean Acupuncture & Moxibustion Medicine Society, and must not be published elsewhere without written permission. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No part of this publication may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from Korean Acupuncture & Moxibustion Medicine Society. All authors are to thoroughly read and sign "Authorship Responsibility and Copyright Transfer (Journal Publishing Agreement)" form of Korean Acupuncture & Moxibustion Medicine Society and submit it with the manuscript through the online submission system.
Licensing information: This is an Open Access journal distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

8. Author fees: https://www.e-jar.org/authors/processing_charg

The author does not have any article processing charge for publication. There is also no publishing fee and Korean Acupuncture & Moxibustion Medicine Society will pay to make the article for open access.

9. Process for the identification of and dealing with allegations of research misconduct: https://www.e-jar.org/ethics/index.php

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.

10. Publication ethics: https://www.e-jar.org/ethics/index.php

JAR adheres completely to the ethical guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Journals((http://publicationethics.org/resources/guidelines) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA: (http://doaj.org/bestpractice).
The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of work of the author and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior.
Authorship
All authors must meet the authorship criteria of ‘Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals' listed on www.icmje.org. Qualifying for authorship is required for all authors and the order of authorship is to be decided between the coauthors. The authorship credit should be based on substantial contributions to:
  • • Conception and design of the study, acquisition of data, or analysis and interpretation of data;
  • • Drafting of the article or revising it critically for important intellectual content, and;
  • • Final approval of the version to be published. Authors should meet all conditions.

One author should be chosen to act as a corresponding author. The corresponding author will be responsible for the entire communications to/from the Editorial Office, editors and etc. In case of multicenter studies, a corporate author directly responsible for the manuscript should be appointed.
Redundant publication and plagiarism
Attempting to publish substantially similar work more than once without attribution of the original source(s) is considered a redundant publication. Definition of being substantially similar can be explained as follows:
  • • At least one of the authors is common to all reports (it is likely to be plagiarism if there are no common authors);
  • • The subject or study populations are same or similar;
  • • The methodology is typically identical or nearly so and;
  • • The results and interpretation varies little or not at all.

If all or part of the subject population has been reported previously, it should be declared in the Materials and Methods and must be appropriately referenced. In cases where authors are concerned with any potential overlap with published manuscripts or manuscripts being reviewed, the authors must include a letter explaining how the manuscript submitted to JAR significantly differs from other materials. For more information, please refer to ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’ (Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142758/).
Secondary publication
It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the ICMJE Recommendations(http://www.icmje.org/urm_main.html).
Complaints and appeal
How the journal will handle complaints and appeals; The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from https://publicationethics.org/appeals.
Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform the cases, they can send a letter to editor For the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
Who is responsible to resolve and handle complaints and appeals?
The Editor, Editorial Board, or Editorial Office is responsible for them.
What may be the consequence of remedy?
It depends on the type or degree of misconduct. The consequence of resolution will follow the guidelines of the Committee of Publication Ethics (COPE).
Conflict of interest statement
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Research ethics
All manuscripts should be prepared under strict observation of research and publication ethics guidelines recommended by the Council of Science Editors, International Committee of Medical Journal Editors and the World Association of Medical Editors. Any study including human subjects or human data must be reviewed and approved by a responsible institutional review board (IRB). For further information on investigations involving human material, please refer to the principles in the Declaration of Helsinki. (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/)
Data statement
To foster transparency, we encourage you to state the availability of your data in your submission. This may be a requirement of your funding body or institution. If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why during the submission process, for example by stating that the research data is confidential.
Human and Animal Rights
Animal experiments should also be reviewed by an appropriate committee (IACUC: Institutional Animal Care and use Committee) for the care and the use of animals. Studies involving pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC: Institutional Biosafety Committee). The editor of JAR may request submission of copies of informed consents from human subjects in all studies or IRB approval documents.
Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs and pedigrees from each subject who can be identified. Articles covering the use of human samples in research and human experiments must be approved by the relevant review committee. Articles covering the use of animals in experiments must be approved by the relevant authorities.
Data Sharing Policy: https://www.e-jar.org/ethics/data_sharing_policy.php
Journal policies on data sharing and reproducibility;
https://www.e-jar.org/ethics/data_sharing_policy.php
JAR follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

Table 1.   Examples of data sharing statements that fulfill these ICMJE requirements*

Element Example 1 Example 2 Example 3 Example 4
Will individual participant data be available (including data dictionaries)? Yes Yes Yes Yes
What data in particular will be shared? All individual participant data collected during the trial, after deidentification. Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Not available
What other documents will be available? Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code Study protocol, statistical analysis plan, analytic code Study protocol Not available
When will data be available (start and end dates)? Immediately following publication. No end date. Beginning at 3 months and ending at 5 years following the article publication. Beginning at 9 months and ending at 36 months following the article publication. Not applicable
With whom? Anyone who wishes to access the data. Researchers who provide a methodologically sound proposal. Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose. Not applicable
For what types of analyses? Any purpose To achieve aims in the approved proposal. For individual participant data meta-analysis. Not applicable
By what mechanism will data be made available? Data are available indefinitely at (link to be included). Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Not applicable
Data are available for 5 years at a third-party website (link to be included). Information regarding submitting proposals and accessing data may be found at (link to be provided).

ICMJE = International Committee of Medical Journal Editors.

*These examples are meant to illustrate a range of, but not all, data sharing options.

11. Publishing schedule: https://www.e-jar.org/about/about.php

Journal of Acupuncture Research is published quarterly on the last day of every March, June, September, and December.

12. Access: https://www.e-jar.org/about/open_access.php

This is an open access journal distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derives(https://creativecommons.org/licenses/by-nc-nd/4.0/). For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

13. Archiving

Journal of Acupuncture Research is accessible without barrier from Korea Citation Index (https://kci.go.kr) and is archived in the National Library of Korea (http://nl.go.kr) in the event the journal is no longer published.

14. Revenues sources

This journal was supported by Korean Acupuncture & Moxibustion Medicine Society and the Korean Federation of Science and Technology Societies Grant funded by Korean Government (Ministry of Education).

15. Advertising

The advertisement price for one whole page is USD 1,000. Depends on number of pages and banner advertisements on the website, the price is negotiable.

16. Direct marketing

Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.


Article and Issues
For this Journal
For Authors
Ethics
Submit Manuscript
Editorial Office
Gil Korean Medical Hospital, Gachon University
Keunumul-Ro, Chung-Ku, Inchoen 22138, Korea
Tel: +82-70-7606-6353,4    Fax: +82-32-232-3334    E-mail: jared@e-jar.org                

Copyright © 2020 by Korean Acupuncture & Moxibustion Medicine Society. All rights reserved.

Developed in M2community

Close layer
prev next